OCD symptoms; ACT + ERP vs wait list; N = 40. Soumee, Z. N. E., Rasouli, A., Lee, E. B., & Mousavi, S. E. (2025). Integrating ACT with ERP for OCD treatment: A randomized controlled trial examining symptom reduction and psychological flexibility mechanisms. Journal of Contextual Behavioral Science,
Overview
This randomized controlled trial with 40 participants compares the effects of integrating Acceptance and Commitment Therapy (ACT) with Exposure and Response Prevention (ERP) against a wait-list control for individuals with OCD symptoms. The study examines symptom reduction and investigates psychological flexibility as a potential mechanism of change. It is intended for researchers and clinicians interested in comparative treatment outcomes for obsessive-compulsive disorder.
- ID
790fb478ea1941d0- Source org
- ACBS
- Author
- Zahra Nejad‐Ebrahim Soumee (Shahid Beheshti University of Medical Sciences), Amirhossein Rasouli (Shahid Beheshti University of Medical Sciences), Eric B. Lee (Southern Illinois University Carbondale), Seyedeh Elnaz Mousavi (Zanjan University of Medical Sciences)
- Published
- 2025-07-01
- OA status
- closed
- DOI
- 10.1016/j.jcbs.2025.100924
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 1
Tags
Verification
- identityok via crossref · score 0.95 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-21T15:41:41.820142+00:00
Cite this entry
BibTeX
@article{allodium:790fb478ea1941d0,
title = {OCD symptoms; ACT + ERP vs wait list; N = 40. Soumee, Z. N. E., Rasouli, A., Lee, E. B., \& Mousavi, S. E. (2025). Integrating ACT with ERP for OCD treatment: A randomized controlled trial examining symptom reduction and psychological flexibility mechanisms. Journal of Contextual Behavioral Science, },
author = {Zahra Nejad‐Ebrahim Soumee and Amirhossein Rasouli and Eric B. Lee and Seyedeh Elnaz Mousavi},
year = {2025},
journal = {ACBS},
doi = {10.1016/j.jcbs.2025.100924},
url = {https://doi.org/10.1016/j.jcbs.2025.100924}
}RIS
TY - JOUR TI - OCD symptoms; ACT + ERP vs wait list; N = 40. Soumee, Z. N. E., Rasouli, A., Lee, E. B., & Mousavi, S. E. (2025). Integrating ACT with ERP for OCD treatment: A randomized controlled trial examining symptom reduction and psychological flexibility mechanisms. Journal of Contextual Behavioral Science, AU - Soumee, Zahra Nejad‐Ebrahim AU - Rasouli, Amirhossein AU - Lee, Eric B. AU - Mousavi, Seyedeh Elnaz PY - 2025 PB - ACBS DO - 10.1016/j.jcbs.2025.100924 UR - https://doi.org/10.1016/j.jcbs.2025.100924 ER -
APA
Soumee, Z. N., Rasouli, A., Lee, E. B., & Mousavi, S. E. (2025). OCD symptoms; ACT + ERP vs wait list; N = 40. Soumee, Z. N. E., Rasouli, A., Lee, E. B., & Mousavi, S. E. (2025). Integrating ACT with ERP for OCD treatment: A randomized controlled trial examining symptom reduction and psychological flexibility mechanisms. Journal of Contextual Behavioral Science, . ACBS. https://doi.org/10.1016/j.jcbs.2025.100924
Related entries
- OCD symptoms. Group ACT vs. wait list. N=72. Lee, S. W., Choi, M., & Lee, S. J. (2023). A randomized controlled trial of group-based acceptance and commitment therapy for obsessive-compulsive disorder. Journal of Contextual Behavioral Science, 27, 45-53. DOI: 10.1016/j.jcbs.2022.11.009
- OCD, Quality of life. ACT vs. CBT/ERP. N=176. Nielsen, S. K. K., Stuart, A. C., Winding, C., Øllgaard, M., Wolitzky-Taylor, K., Daniel, S. I. F., Vangkilde, S., Rosenberg, N., Hageman, I., & Jørgensen, M. B. (2025). Group acceptance and commitment therapy versus cognitive behavioral therapy/exposure
- OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di
- An Open Trial of Acceptance and Commitment Therapy With Exposure and Response Prevention in an Intensive Outpatient Setting for Adults With OCD
- OCD symptoms. TAU w/ medications vs TAU w/ medications + ACT. N=62. Akhouri, D., Hamza, S., Kumar, S., & Reyazuddin, M. (2023). Acceptance and commitment therapy as an add-on treatment for the management of patients with obsessive-compulsive disorder. Industrial Psychiatry Journal, 32 (Suppl 1), S17
- OCD. ACT vs control group. N=44 Lee, S., Choi, M., & Lee, S. (2022). Effectiveness of a Group-Based Acceptance and Commitment Therapy for Obsessive-Compulsive Disorder in a University Hospital. Journal of the Korean Society of Biological Therapies in Psychiatry, 28 (1), 49-56. Retrieved from: https:
- Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse
- OCD symptoms; Sertraline + ACT) vs transcranial magnetic stimulation. N=63. Zou, J. Z., Wu, S. L., Yuan, X., Hu, Z. Z., Tang, J., & Hu, M.R. (2022). Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive-Compulsive Disorder. Frontiers in Psychiatry
- Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
- Mindfulness-based exposure and response prevention for obsessive compulsive disorder: study protocol for a pilot randomised controlled trial